Table 1. Correlation between RPL22L1 expression and clinicopathological features in the cytoplasm of ovarian cancer (OC) tissues.
| Variables | Number | RPL22L1 expression | P value | |||
|---|---|---|---|---|---|---|
| Low expression(0) | High expression(1–3) | |||||
| Age | ||||||
| ≤50 | 230 | 69 | (30.0%) | 161 | (70.0%) | 0.102 |
| >50 | 200 | 46 | (23.0%) | 154 | (77.0%) | |
| Tumor differentiation | ||||||
| Well to moderate | 177 | 62 | (35.0%) | 115 | (65.0%) | 0.002* |
| Poor | 161 | 32 | (19.9%) | 129 | (80.1%) | |
| Stage | ||||||
| 1 | 211 | 75 | (35.5%) | 136 | (64.5%) | 0.000* |
| 2–4 | 219 | 40 | (18.3%) | 179 | (81.7%) | |
| TNM system | ||||||
| T | ||||||
| T1 | 214 | 76 | (35.5%) | 138 | (64.5%) | 0.000* |
| T2–4 | 216 | 39 | (18.1%) | 177 | (81.9%) | |
| N | ||||||
| N0 | 354 | 105 | (29.7%) | 249 | (70.3%) | 0.003* |
| N1–3 | 76 | 10 | (13.2%) | 66 | (86.6%) | |
| M | ||||||
| M0 | 383 | 108 | (28.2%) | 275 | (71.8%) | 0.052 |
| M1 | 47 | 7 | (14.9%) | 40 | (85.1%) | |
* P < 0.05, all P-values were calculated for Pearson’s χ2 tests.